GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Rosalind, a specialised AI model designed for life sciences. Built to assist researchers with complex biological problems, ...

GPT-Rosalind, a specialized AI model developed by OpenAI, focuses on life sciences and biomedical research. The launch ...

OpenAI has introduced an early version of an AI model designed to expedite drug discovery, competing directly with tech giant ...

Rosalind, an AI model designed to accelerate drug discovery and support biology-related research work. Read more here.

OpenAI has introduced a new AI model called GPT-Rosalind, designed to support research across biology, drug discovery and translational medicine.

Numbers are the language of science—yet in research articles, they are often buried within the text and difficult to analyze.

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...

The model will be available initially as a research preview to some of the company’s business customers, OpenAI said ...

A new study has revealed that when a large language model (LLM) trains another AI, it can pass on unintended biases. This ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...